缬沙坦治疗高血压病伴蛋白尿35例

Efficacy of valsartan in treatment of hypertension complicated by proteinunia: report of 35 cases

下载PDF

导出

作者许贤利

机构地区北京军区司令部门诊部

出处《华北国防医药》 2002年第6期431-432,共2页 Medical Journal of Beijing Military Region

关键词缬沙坦治疗高血压蛋白尿抗高血压药尼群地平合并症

参考文献7

1Cohen D,Dodds R,Viberti G. Effect of protein restriction in insulin dependent diabetics at risk of nephropathy[J]. Br Med J,1987,294:795-798.
2Redon J. Treatment of patients with essential hypertension and microalbuminuria[J]. Drugs, 1997,54:857-866.
3崔吉君.高血压指南(资料连载)[J].北京军区医药,2000,12(1):18-19. 被引量：1
4苏哲坦.血管紧张素Ⅱ受体亚型Ⅰ拮抗剂及其临床应用[J].心功能杂志,1997,9(1):24-26. 被引量：1
5Bremner AD,Baur M,Oddou Stock P,et al. Valsartan:long-term efficacy and tolerability compared to lisinopril in elderly patients with essential hypertension [ J]. Clin Exp Hypertens, 1997,19:1263-1285.
6Cifkova R,Peleska J,Hradec J,et al. Valsartan and atenolol in patients with severe essential hypertension [J]. J Hum Hypertens, 1998,12: 563-567.
7Mann JF. Valsartan and the kidney: present and future [ J ]. J Cardiovasc Pharmacol. 1999,33 ( Supple 1 ): S37-S40.

华北国防医药

2002年第6期

内容加载中请稍等...